dr. pagel on time-limited therapy in cll
Published 4 years ago • 192 plays • Length 0:59Download video MP4
Download video MP3
Similar videos
-
1:55
dr. pagel on the elevate-tn trial in cll
-
1:05
dr. woyach on the utility of time-limited therapies in cll
-
2:20
dr. pagel on ongoing research with btk inhibitors in cll
-
1:34
time-limited vs continuous therapy in cll treatment
-
1:36
dr. davids on cost effectiveness of time-limited therapy with venetoclax/obinutuzumab in cll
-
3:35
an insight into time-limited therapy in cll
-
1:24
time-limited therapy in cll
-
3:13
selection for time-limited & continuous therapy in cll
-
5:03
understanding patient perspectives in cll treatment
-
2:59
clinical trial updates and time-limited therapy in cll
-
2:07
moving towards time-limited treatment in frontline cll
-
0:57
unanswered questions in frontline cll treatment
-
1:05
dr. smith on using venetoclax versus ibrutinib in cll
-
2:11
dr. awan on time-limited treatments in cll
-
1:54
dr. fakhri on selecting the optimal treatment in cll
-
0:49
considering patient preference when selecting between continuous and time-limited therapy in cll
-
1:12
dr. mato on immunotherapy options in cll
-
1:16
dr. jones on long-term outcomes with ibrutinib in cll
-
1:51
dr. smith on frontline treatment considerations in cll